article · MOLECULAR SCIENCES AND APPLICATIONS
Endocrine-disrupting chemicals are widespread environmental contaminants capable of interacting with the human endocrine system, resulting in harmful health consequences. These substances continue to be routinely incorporated into everyday consumer goods, making human exposure common despite ongoing public health warnings. Extensive experimental and epidemiological research links these chemicals to broad health risks, prompting growing calls to reduce population exposure. Evidence indicates a connection between endocrine-disrupting substances and an increased risk of developing hormone-sensitive malignancies. Specifically, exposure correlates with higher susceptibility to breast, ovarian, uterine, prostate, and thyroid cancers. This review synthesises existing research to map how exposure to these pervasive chemicals relates to cancer development.
Endocrine-disrupting chemicals are found in many ordinary consumer items, meaning most people are regularly exposed to them. Understanding the connection between these compounds and hormone-sensitive cancers helps guide public health initiatives, informs preventative actions, and supports the rationale for reducing human exposure to hazardous everyday materials.
The abstract does not indicate an application pathway, as it provides a general review of cancer risks rather than detailing a specific product, technology, or commercial process.
AI-generated from the published abstract. Always read the original work before citing.
Endocrine-disrupting chemicals (EDCs), which are environmentally prevalent compounds, have the ability to interact with the body's endocrine system and thus exert detrimental effects on human health. Despite persistent concerns over public health, endocrine-disrupting chemicals (EDCs) remain integral components of commonplace consumer products, rendering them ubiquitous pollutants for individuals. In light of the numerous epidemiological and experimental studies that have established a connection between endocrine-disrupting chemicals and adverse effects on human health, there has been an increased emphasis on mitigating human exposure to these compounds. There exists a correlation between endocrine-disrupting drugs and adverse impacts on human health, as well as an elevated susceptibility to hormone-sensitive cancers such as breast, uterine, ovarian, prostate, and thyroid cancers. The objective of this study was to provide a comprehensive overview of previous studies investigating the relationship between endocrine-disrupting chemicals and the development of cancer.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.37394/232023.2023.3.2
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
